|  

Feldman and Pike's Vitamin D - Volume Two - Disease and Therapeutics 5th Edition



Size :23.1 MB
Peers : Seeders : 0      Leechers : 0
Added : 4 months ago » by freecoursewb » in Other
Language : English
Last Updated :4 months ago
Info_Hash :27BC4BEB9FCCFA134428D8102C9066A02B56023F

Torrent File Contents

Feldman and Pike's Vitamin D - Volume Two - Disease and Therapeutics 5th Edition
  Get Bonus Downloads Here.url
  -  181 Bytes

  ~Get Your Files Here !/Bonus Resources.txt
  -  386 Bytes

  ~Get Your Files Here !/FeldmanandPike’sVitaminDVolume2.pdf
  -  23.05 MB



Torrent Description

Feldman and Pike's Vitamin D: Volume Two: Disease and Therapeutics 5th Edition



https://CourseWikia.com

2024 | ISBN: 0323913385 | English | 1381 pages | True PDF | 23 MB

Vitamin D deficiency is a worldwide problem linked to numerous diseases affecting men, women, and children of all ages. Enormous progress in the study of vitamin D has been made since the first edition of this highly-acclaimed book was published nearly 20 years ago, and current research continues to draw headlines. Feldman and Pike’s Vitamin D, Fifth Edition continues to build on the successful formula from previous editions, taking the reader from the basic elements of fundamental research to the most sophisticated concepts in therapeutics. The two comprehensive volumes provide investigators, clinicians, and students with a comprehensive, definitive, and up-to-date compendium of the diverse scientific and clinical aspects of vitamin D, where each area is covered by both basic and clinical experts in the field.

In Volume I: Biochemistry, Physiology and Diagnostics, international experts in endocrinology, bone biology, and human physiology take readers through the basic research of vitamin D. This impressive reference presents a comprehensive review of the multi-faceted actions of vitamin D relating both to skeletal and extra-skeletal action. Researchers from all areas of vitamin D will gain insight into how clinical observations and practices can feed back into the research cycle and will, therefore, be able to develop more targeted genomic and proteomic insights into the mechanisms of disease.